Article references (45 references )


  1. Molyneux DH, Hopkins DR and Zagaria N. Disease eradication, elimination and control: The need for accurate and consistent usage. Trends Parasitol. 2004 Aug;20(8):347-51. PubMed | Google Scholar

  2. Fenner F. Nature, nurture and my experience with smallpox eradication. Med J Aust. 1989; 171(11-12):638-41. PubMed | Google Scholar

  3. Foege WH. The Global Elimination of Measles. Pub Hlth Reports. Sept-Oct 1982; 97:402-5. PubMed | Google Scholar

  4. Hopkins DR et al. The Case for Global Measles Eradication. Lancet. 1982; 319: 1396-1398. PubMed | Google Scholar

  5. Kofi Annan. United Nations Foundation Board Member, calling on the W.H.O. Executive Board to set an Eradication Date for Measles. Accessed 30 April 2017

  6. Whitty CJ. Milroy Lecture: Eradication of Disease: Hype, hope and reality. J Royal College Physicians. 2014 Aug;14(4):419-21. PubMed | Google Scholar

  7. Durrheim DN, Crowcroft NS. The price of delaying measles eradication. Lancet Public Health. 2017;2:e130-e131. PubMed | Google Scholar

  8. Moss WJ, Strebel P. Biological Feasibility of Measles Eradication. J Inf Dis. 2011 Jul;204 Suppl 1:S47-53. PubMed | Google Scholar

  9. World Health Organization. Proceedings of the Global Technical Consultation to Assess the Feasibility of Measles Eradication, 28-30 July 2010. J Infect Dis. 2011 Jul;204 Suppl 1:S4-13. PubMed | Google Scholar

  10. W.H.O. Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010 –Summary, Conclusions and Recommendations, Weekly Epidemiological Record, 2011;86:1-16. PubMed | Google Scholar

  11. Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. Nosocomial Transmission of Measles: An Updated Review. Vaccine. 2012 Jun 8;30(27):3996-4001. PubMed | Google Scholar

  12. Mulholland K. Measles and Pertussis in Developing Countries with Good Vaccine Coverage. Lancet. 1995 Feb 4;345(8945):305-7. PubMed | Google Scholar

  13. Scott P, Moss WJ, Gilani Z, Low N. Measles vaccination in HIV-infected children: Meta-analysis of safety and immunogenicity. J Infect Dis. 2011 Jul;204 Suppl 1:S164-78. PubMed | Google Scholar

  14. Adhikari BB, Goodson JL, Chu SY, Rota PA, Meltzer MI. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development”. Drugs RD. 2016 Dec;16(4):327-338. PubMed | Google Scholar

  15. Haji A et al. “Reducing routine vaccination dropout rates: Evaluating two interventions in three Kenya districts, 2014. BMC Public Health. 2016;16:152. PubMed | Google Scholar

  16. Eze GU, Adeleye OO. Enhancing Routine Immunization Performance using Innovative Technology in an Urban Area of Nigeria. West African Journal of Medicine. 2015;34(1):3-10. PubMed | Google Scholar

  17. Bangure D, Chirundu D, Gombe N et al. Effectiveness of short message services reminder on childhood immunization programme in Kadoma, Zimbabwe - a randomized controlled trial, 2013. BMC Public Health. 2015;15:137. PubMed | Google Scholar

  18. De Quadros CA. Can measles be eradicated globally?. Bull World Health Organ. 2004 Feb;82(2):134-8. Epub 2004 Mar 16. PubMed | Google Scholar

  19. Biellik R et al. First five years of experience with measles elimination in South Africa, 1996-2000”. Lancet. 2002;359:1564-1568. PubMed | Google Scholar

  20. Njeru I, Ajack Y, Muitherero C et al. Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? A cross-sectional study. Pan Afr Med J. 2016;24:120. PubMed | Google Scholar

  21. Kriss JL, Goodson J, Machekanyanga Z et al. Vaccine receipt and vaccine card availability among children of the Apostolic faith: analysis from the 2010-2011 Zimbabwe demographic and health survey. Pan Afr Med J. May 2016;24:47. PubMed | Google Scholar

  22. Ozawa S, Clark S, Portnoy A et al. Return on Investment from Childhood Immunization in Low- and Middle-Income Countries, 2011-20. Health Affairs. 2016 Feb;35(2):199-207. PubMed | Google Scholar

  23. Thompson K, Odahowski CL. The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies. Risk Analysis. 2016 Jul;36(7):1357-82. PubMed | Google Scholar

  24. Thompson K, Odahowski CL. Global eradication of measles: an epidemiologic and economic evaluation. J Infect Dis. 2011 Jul;204 Suppl 1:S98-106. PubMed | Google Scholar

  25. Baigumira JB, Levin A, Burgess C et al. Assessing the Cost-Effectiveness of Measles Elimination in Uganda: Local Impact of a Global Eradication Program. J Infect Dis. 2011 Jul;204 Suppl 1:S116-23. PubMed | Google Scholar

  26. Progress towards regional measles elimination – worldwide, 2000-2015. Weekly Epid Rec. 2016;91:525-526. Google Scholar

  27. Henderson DA. Eradication: lessons from the Past. Bull World Health Organ. 1998;76 Suppl 2:17-21. PubMed | Google Scholar

  28. Masresha B et al. “The effect of targeted wide-age range SIAs in reducing measles incidence in the African Region.” Submitted for publication. Google Scholar

  29. World Health Organization. Planning and Implementing High Quality Supplemental Immunization Activities for Injectable Vaccines using the Example of Measles and Rubella Vaccines, Geneva; 2016. Google Scholar

  30. Gardy JL et al. Whole-genome sequencing of measles virus genotypes H1 and D8 during outbreaks of infection following the 2010 olympic winter games reveals viral transmission routes. J Infect Dis. 2015 Nov 15;212(10):1574-8. PubMed | Google Scholar

  31. Thompson KM et al. Group Report: Developing an Eradication Investment Case, Chapter 10 in Cochi SL and Dowdle WR (eds). Disease Eradication in the 21st Century: Implications for Global Health. Cambridge, MA, MIT Press; 2011. PubMed | Google Scholar

  32. Mbabazi WB et al. Innovations in communication technologies for measles supplemental immunization activities: Lessons from Kenya measles vaccination campaign, November 2012. Health Policy Plan. 2015 Jun;30(5):638-44. PubMed | Google Scholar

  33. Kriss JL et al. Development of the World Health Organization measles assessment programmatic risk assessment tool using experience from the 2009 measles outbreak in Namibia. Risk Anal 2016; 2016 Feb 19. [Epub ahead of print]. PubMed | Google Scholar

  34. Sniadack DH et al. Roadmap to elimination-standard measles and rubella surveillance. Weekly Epidemiological Record. 2017 Mar 3;92(9-10):97-105. PubMed | Google Scholar

  35. Adhikari BB et al. Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: the case for further research and development. Drugs RD. 2016;16:327-338. PubMed | Google Scholar

  36. Haji A et al. Reducing routine vaccination dropout rates: Evaluating two interventions in three Kenyan districts, 2014. BMC Public Health. 2016;16:152. PubMed | Google Scholar

  37. Keegan R, Dabbagh A, Strebel PM, Cochi SL. Comparing measles with previous eradication programs: enabling and constraining factors. J Infect Dis. 2011 Jul;204 Suppl 1:S54-61. PubMed | Google Scholar

  38. Aylward B, Hennessey KA, Zagaria N, Olivé JM, Cochi S. When is a Disease Eradicable? 100 Years of Lessons Learned. Am J Pub Hlth. 2000 Oct;90(10):1515-20. PubMed | Google Scholar

  39. Rota PA, Moss WJ, Takeda M et al. “Measles,” Nature Reviews: Disease Primers, 2016; 2: p. 4. Google Scholar

  40. Levin A, Burgess C, Garrison LP Jr et al. Global Eradication of Measles: An Epidemiologic and Economic Evaluation. J Infect Dis. 2011 Jul;204 Suppl 1:S98-106. PubMed | Google Scholar

  41. Cutts F, Steinglass R. Should Measles be Eradicated?. BMJ. 1998;316:765. PubMed | Google Scholar

  42. Thompson KM et al. Group Report: Developing an Eradication Investment Case, Chapter 10 in Cochi SL and Dowdle WR (eds)., Disease Eradication in the 21st Century: Implications for Global Health. Cambridge, MA: MIT Press: 2011. Google Scholar

  43. Sniadack DH, Orenstein WA. A measles eradication goal is upon us; can rubella and congenital rubella syndrome be far behind?. Vaccine. 2013 May 31;31(24):2659-60. PubMed | Google Scholar

  44. Thompson KM, Odahowski CL. Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions. Risk Anal. 2016;7:1297-1314. Google Scholar

  45. Strebel P. Measles. Bull World Health Org. 1998;76 Suppl 2:154-155. PubMed | Google Scholar

 

 

 

 

 

 

 

 

<